Emergent Biosolutions (EBS) has a market capitalization of $466.3M, based on 53.35M shares at a price of $8.74 (up 6.3% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
September 2025 | $8.29 | 16,496,484 | 53,351,099 | $442,280,610.71 |
August 2025 | $8.30 | 29,595,402 | 53,351,099 | $442,814,121.70 |
July 2025 | $5.88 | 23,895,400 | 53,351,099 | $313,704,462.12 |
June 2025 | $6.38 | 26,942,408 | 54,200,000 | $345,796,000.00 |
May 2025 | $6.32 | 29,795,300 | 54,200,000 | $342,544,000.00 |
April 2025 | $5.34 | 23,274,356 | 54,200,000 | $289,428,000.00 |
March 2025 | $4.86 | 31,233,989 | 57,300,000 | $278,478,000.00 |
February 2025 | $7.48 | 20,766,468 | 57,300,000 | $428,604,000.00 |
January 2025 | $11.25 | 19,751,101 | 57,300,000 | $644,625,000.00 |
December 2024 | $9.56 | 22,652,561 | 54,200,000 | $518,152,000.00 |
November 2024 | $10.12 | 32,384,276 | 54,200,000 | $548,504,000.00 |
October 2024 | $9.06 | 29,910,505 | 54,200,000 | $491,052,000.00 |
September 2024 | $8.35 | 45,413,791 | 55,600,000 | $464,260,000.00 |
August 2024 | $8.31 | 94,849,658 | 55,600,000 | $462,036,000.00 |
July 2024 | $12.71 | 60,689,045 | 55,600,000 | $706,676,000.00 |
June 2024 | $6.82 | 48,214,806 | 52,600,000 | $358,732,000.00 |
May 2024 | $5.70 | 234,848,386 | 52,600,000 | $299,820,000.00 |
April 2024 | $1.88 | 22,376,385 | 52,600,000 | $98,888,000.00 |
March 2024 | $2.53 | 41,134,648 | 52,200,000 | $132,066,000.00 |
February 2024 | $3.23 | 124,935,471 | 52,200,000 | $168,606,000.00 |
January 2024 | $1.67 | 24,878,102 | 52,200,000 | $87,174,000.00 |
December 2023 | $2.40 | 28,756,317 | 51,900,000 | $124,560,000.00 |
November 2023 | $2.14 | 29,957,470 | 51,900,000 | $111,066,000.00 |
October 2023 | $2.09 | 30,550,332 | 51,900,000 | $108,471,000.00 |
September 2023 | $3.40 | 51,906,450 | 51,800,000 | $176,120,000.00 |
